ATE197545T1 - Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus - Google Patents
Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterusInfo
- Publication number
- ATE197545T1 ATE197545T1 AT94902962T AT94902962T ATE197545T1 AT E197545 T1 ATE197545 T1 AT E197545T1 AT 94902962 T AT94902962 T AT 94902962T AT 94902962 T AT94902962 T AT 94902962T AT E197545 T1 ATE197545 T1 AT E197545T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- uterus
- aspirin
- production
- medicinal product
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001138 acetylsalicylic acid Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 210000004291 uterus Anatomy 0.000 title abstract 2
- 230000008081 blood perfusion Effects 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 230000010412 perfusion Effects 0.000 abstract 2
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000032692 embryo implantation Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Semiconductor Lasers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929227123A GB9227123D0 (en) | 1992-12-30 | 1992-12-30 | Method |
| PCT/GB1993/002657 WO1994015613A1 (en) | 1992-12-30 | 1993-12-24 | Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE197545T1 true ATE197545T1 (de) | 2000-12-15 |
Family
ID=10727336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94902962T ATE197545T1 (de) | 1992-12-30 | 1993-12-24 | Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5760024A (de) |
| EP (1) | EP0691847B1 (de) |
| JP (1) | JP3881690B2 (de) |
| AT (1) | ATE197545T1 (de) |
| AU (1) | AU683035B2 (de) |
| CA (1) | CA2151476C (de) |
| DE (1) | DE69329687T2 (de) |
| DK (1) | DK0691847T3 (de) |
| ES (1) | ES2151922T3 (de) |
| GB (1) | GB9227123D0 (de) |
| GR (1) | GR3035358T3 (de) |
| PT (1) | PT691847E (de) |
| WO (1) | WO1994015613A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9227123D0 (en) * | 1992-12-30 | 1993-02-24 | Applied Research Systems | Method |
| EP1123687A3 (de) * | 2000-02-10 | 2004-02-04 | Aloka Co., Ltd. | Diagnostisches Ultraschallgerät |
| US6695766B2 (en) | 2002-04-26 | 2004-02-24 | Olympia Womens Health | Magnetic embryo transfer |
| EP1670902A4 (de) * | 2003-09-08 | 2008-05-07 | Univ Texas | Verfahren und zusammensetzung zur verbesserung der embryoentwicklung in vitro durch ergänzen des kulturmediums mit prostaglandin oder einem prostaglandinanalogen |
| CA2566851C (en) | 2004-05-17 | 2015-11-10 | The General Hospital Corporation | Compositions comprising female germline stem cells and methods of use thereof |
| US7705197B2 (en) * | 2005-01-19 | 2010-04-27 | University Of Tennessee Research Foundation | Embryo development and survival |
| US7615585B2 (en) * | 2007-04-19 | 2009-11-10 | Troy Corporation | Degassing compositions for curable coatings |
| EP3498826A1 (de) | 2011-04-14 | 2019-06-19 | The General Hospital Corporation | Zusammensetzungen und verfahren zur autologen energieübertragung in mitochondrialen keimbahnen |
| US9845482B2 (en) | 2011-06-29 | 2017-12-19 | The General Hospital Corporation | Compositions and methods for enhancing bioenergetic status in female germ cells |
| CN117531006B (zh) * | 2023-10-10 | 2025-02-11 | 山东奥克斯畜牧种业有限公司 | 一种提高牛胚胎移植受胎率的组合制剂及其制备方法与应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO91014B1 (ro) * | 1984-12-08 | 1987-02-28 | Raisa Motocescu | Gel hormonal si antiprostaglandinic |
| DE69027992D1 (de) * | 1989-05-05 | 1996-09-05 | North Sydney Area Health Serv | Steigerung der fruchtbarkeit |
| GB9227123D0 (en) * | 1992-12-30 | 1993-02-24 | Applied Research Systems | Method |
-
1992
- 1992-12-30 GB GB929227123A patent/GB9227123D0/en active Pending
-
1993
- 1993-12-24 DK DK94902962T patent/DK0691847T3/da active
- 1993-12-24 PT PT94902962T patent/PT691847E/pt unknown
- 1993-12-24 AU AU57113/94A patent/AU683035B2/en not_active Ceased
- 1993-12-24 JP JP51578094A patent/JP3881690B2/ja not_active Expired - Fee Related
- 1993-12-24 AT AT94902962T patent/ATE197545T1/de not_active IP Right Cessation
- 1993-12-24 WO PCT/GB1993/002657 patent/WO1994015613A1/en not_active Ceased
- 1993-12-24 US US08/464,785 patent/US5760024A/en not_active Expired - Fee Related
- 1993-12-24 DE DE69329687T patent/DE69329687T2/de not_active Expired - Fee Related
- 1993-12-24 EP EP94902962A patent/EP0691847B1/de not_active Expired - Lifetime
- 1993-12-24 CA CA002151476A patent/CA2151476C/en not_active Expired - Fee Related
- 1993-12-24 ES ES94902962T patent/ES2151922T3/es not_active Expired - Lifetime
-
1997
- 1997-12-05 US US08/985,590 patent/US6100249A/en not_active Expired - Fee Related
-
2001
- 2001-02-02 GR GR20010400183T patent/GR3035358T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2151922T3 (es) | 2001-01-16 |
| JP3881690B2 (ja) | 2007-02-14 |
| DE69329687D1 (de) | 2000-12-21 |
| PT691847E (pt) | 2001-02-28 |
| DK0691847T3 (da) | 2000-12-11 |
| US6100249A (en) | 2000-08-08 |
| GB9227123D0 (en) | 1993-02-24 |
| WO1994015613A1 (en) | 1994-07-21 |
| CA2151476A1 (en) | 1994-07-25 |
| EP0691847A1 (de) | 1996-01-17 |
| AU5711394A (en) | 1994-08-15 |
| AU683035B2 (en) | 1997-10-30 |
| EP0691847B1 (de) | 2000-11-15 |
| GR3035358T3 (en) | 2001-05-31 |
| DE69329687T2 (de) | 2001-05-10 |
| JPH08510717A (ja) | 1996-11-12 |
| US5760024A (en) | 1998-06-02 |
| CA2151476C (en) | 2005-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT799209E (pt) | Novas sulfonamidas | |
| SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
| ATE213164T1 (de) | Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids | |
| DE69521512D1 (de) | Neues pharmazeutisches präparat zur schmerzbehandlung | |
| KR960701051A (ko) | 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases) | |
| ATE217197T1 (de) | Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa | |
| ATE197545T1 (de) | Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus | |
| DE3850154D1 (de) | Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression. | |
| ES2038216T3 (es) | Procedimiento para la preparacion de 5-(3-alquil-5-t-butil-4-hidroxi-fenil)-2-amino-6h-1,3,4-tiadazinas y su empleo. | |
| ATE223721T1 (de) | Edelfosin zur behandlung von hirntumoren | |
| DE69432124D1 (de) | Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes | |
| DE69522702D1 (de) | Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält | |
| DE50100833D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| ATE194076T1 (de) | Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
| DE69626301D1 (de) | Verwendung von allylaminderivaten wie terbinafin zur herstellung eines medikaments zur behandlung von mit einer helicobacter pylori infektion zusammenhängenden erkrankungen | |
| ATE183390T1 (de) | Verwendung einer kombination von antineoplastonen zur herstellung eines arzneimittels zur behandlung der neurofibromatose | |
| DE69428797D1 (de) | Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden | |
| ES2137665T3 (es) | Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos. | |
| ATE312611T1 (de) | Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen | |
| ATE232867T1 (de) | Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen | |
| DE69421705D1 (de) | Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen | |
| ATE203671T1 (de) | Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen | |
| DE69319140D1 (de) | 4-guanidinobutyramid zur verbesserung des blutkreislaufs | |
| DK0868181T3 (da) | Anvendelse af alfa,alfa-diphenyleddikesyre-4-(N-methyl-piperidyl)-estere som spasmoanalgetikum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |